Prescription Lens Market Size, Share, Growth Analysis, By Distribution Channel(Offline, Online), By Lens Coating(Anti-reflective, Scratch Resistant Coating, Anti-Fog Coating, Ultraviolet Treatment), By Application(Myopia, Hyperopia/Hypermetropia, Astigmatism, Presbyopia), By Type(Single Vision, Bifocal, Trifocal, Progressive), By Region - Industry Forecast 2024-2031

Prescription Lens Market size was valued at USD 45.3 billion in 2019 and is poised to grow from USD 47.7 billion in 2023 to USD 66.7 billion by 2031, growing at a CAGR of 5.3% in the forecast period (2024-2031).

Prescription sunglasses are extremely beneficial in protecting the eyes from harmful ultraviolet rays that can end up causing permanent eye damage. Because of their various shapes and coatings, these glasses aid in resolving the issue of projecting light onto the retina for improved vision. Growing acceptance and usage of eyewear products, including prescription eyewear, is a growth factor for the market.

During the forecast period, the global prescription lens market is expected to grow significantly. Patients with vision problems are often unaware of their condition and do not seek treatment. According to the World Health Organization (WHO), URE was responsible for 42.0% of all visual impairments worldwide in 2019. The rise in refractive error-related visual impairment (primarily astigmatism and myopia) and the resulting rise in uncorrected refractive error (URE) in patient populations will drive revenue growth in the next global prescription lens market. This is the most important factor to consider. Cases of vision impairment caused by vision problems are on the rise. The majority of these situations go unnoticed at first and contribute to the growing number of uncorrected refractive errors (URE). People with the disease of refractive errors are often unaware of their condition and receive no treatment. As a result, various organizations focusing on the treatment and detection of refractive errors are being formed to control the rise in URE.

Sightsavers, a non-profit organization with operations in over 30 countries, focuses primarily on the African and Asian continents. To provide advanced and affordable ophthalmic treatment, the organization allies with local, regional, national, and international partners and governments. To address the issue of URE, the organization devised a refractive error strategy. With its dual-track approach, the organization provides refractive error services. Furthermore, the organization is expanding its program partnerships and forming collaborations to improve URE services. The presence of such organizations, as well as growing awareness of refractive error treatment, are expected to drive the market.

US Prescription Lens Market  is poised to grow at a sustainable CAGR for the next forecast year.